Yüklüyor......
Prognostic Biomarkers for Response to VEGF Targeted Therapy for Renal Cell Carcinoma
Our improved understanding of renal carcinoma disease biology over the past three decades has led to the discovery and FDA-approval of five novel therapies targeting specific molecules in the VEGF biochemical pathway. In order to properly select patients who will receive maximal therapeutic benefit...
Kaydedildi:
| Yayımlandı: | Urol Clin North Am |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4864362/ https://ncbi.nlm.nih.gov/pubmed/26614032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ucl.2015.08.009 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|